Ling Ni

10PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityTumour immunologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 06, 2026
Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Birui Pan, Qinli Sun, Ruifeng Li

|Nov 13, 2025
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.

Bowen Xie, Bowen Yuan, Xiaohong Zhao

|Feb 05, 2025
Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39.

Sang-Nee Tan, Jing Hao, Jing Ge

|Oct 28, 2024
Immunotherapy Vaccines for Prostate Cancer Treatment.

Jide He, Jialong Wu, Ziang Li

|Aug 22, 2024
Potential mechanisms of cancer stem-like progenitor T-cell bio-behaviours.

Ling Ni

|Oct 28, 2023
Advances in mRNA-Based Cancer Vaccines.

Ling Ni

Pageof 2